AI drug discovery company Genesis Therapeutics scores $200 million in new funding

“We founded the company with the straightforward vision of transformative AI technologies for transformative therapies for patients,” said co-founder and CEO Evan Feinberg.

Food Friday: Where to find the best soul food in Albuquerque

Microsoft to vacate more Eastside office space as leases end

Bham broker closes massive office portfolio sale

Turtle Bay Resort has a new executive chef

PNC Bank’s investment chief Amanda Agati sees trouble ahead for stocks

Food Friday: ABQ’s favorite spot for a doughnut

Block secures $60M refinancing for Galleria apartments

Duesenberg’s will become Doozy’s as new owners revamp staple Catonsville diner

AI drug discovery company Genesis Therapeutics scores $200 million in new funding

Previous Fulcrum swings back up after FDA lifts clinical hold

Next St. Edward's University ventures into nursing education

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Bill package allowing developers to turn shuttered retail centers into housing heads to Newsom’s desk

Color Book hit for JVA

King of Prussia health care technology firm Lyric raises $90.9M, adds golfer Rory McIlroy as investor

Tampa Bay among the top five hottest rental markets in Florida

Munsch Hardt opts to keep HQ at Ross Tower with new lease

CBF Morning Run: What you need to know today, a shopping adventure and wearing shorts in winter

MENU

FirstStar Group

More Stories

Report: Four Tampa Bay property insurers post losses in 2022

Previous Fulcrum swings back up after FDA lifts clinical hold

Next St. Edward's University ventures into nursing education

firststargroup

Related Posts

Suggested Posts

MENU

FirstStar Group

More Stories